Search Results 9971-9980 of 16398 for Melanie Swift MD

  1. Muscle strains - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...

  2. Publications - Matthew R. Powell, Ph.D., L.P. - Mayo Clinic

    Powell MR, Brown AW, Klunk D, Geske JR, Krishnan K, Green C, Bergquist TF. Injury Severity and Depressive Symptoms in a Post-acute Brain Injury ...

  3. Pulmonary embolism - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...

  4. Pulmonary embolism - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...

  5. Pulmonary embolism - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...

  6. Stress management - Doctors & Departments - Mayo Clinic

    Bhagra, Anjali M.D., M.B.A.. Minnesota. Chesak, Sherry S. Ph.D., M.S., R.N.. Minnesota. Croghan, Ivana T. Ph.D. Minnesota. Jowsey-Gregoire, Sheila G. M.D..

  7. Frontotemporal dementia - Doctors and departments - Mayo Clinic

    Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first. So the mission and research here is ...

  8. A Study of TCD601 in de Novo Renal Transplant Recipients - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  9. A Study to Evaluate Whether Retinal Vasoreactivity is a Marker for Cerebrovascular Heath - Mayo Clinic

    The purpose of this study is to describe cerebral and retinal vasoreactivity in patients with cerebral small vessel disease (SVD) vs. healthy control, to ...

  10. A 4-Week Study Of The Safety, Efficacy, And Pharmacokinetics Of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] In Subjects With Parkinson's Disease And Excessive Sleepiness - Mayo Clinic

    A 4-Week Study Of The Safety, Efficacy, And Pharmacokinetics Of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] In Subjects With Parkinson's Disease ...